Michel Velez, MD, medical oncologist at Holy Cross Hospital, discusses the management of neratinib (Nerlynx)-associated diarrhea in patients with early-stage HER2-positive breast cancer.
Michel Velez, MD
Advertisement
Articles by Michel Velez, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer
3
Dr Hoffmann on the Significance of Efficacy Data for Sonrotoclax Plus Zanubrutinib in MCL
4
Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC
5